Tracking coverage, dropout and multidimensional equity gaps in immunisation systems in West Africa, 2000-2017.

Immunisation West Africa coverage dropouts inequality

Journal

BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275

Informations de publication

Date de publication:
2019
Historique:
received: 14 05 2019
revised: 03 07 2019
accepted: 23 07 2019
entrez: 1 10 2019
pubmed: 1 10 2019
medline: 1 10 2019
Statut: epublish

Résumé

Several West African countries are unlikely to achieve the recommended Global Vaccine Action Plan (GVAP) immunisation coverage and dropout targets in a landscape beset with entrenched intra-country equity gaps in immunisation. Our aim was to assess and compare the immunisation coverage, dropout and equity gaps across 15 West African countries between 2000 and 2017. We compared Bacille Calmette Guerin (BCG) and the third dose of diphtheria-tetanus-pertussis (DTP3) containing vaccine coverage between 2000 and 2017 using the WHO and Unicef Estimates of National Immunisation Coverage for 15 West African countries. Estimated subregional median and weighted average coverages, and dropout (DTP1-DTP3) were tracked against the GVAP targets of ≥90% coverage (BCG and DTP3), and ≤10% dropouts. Equity gaps in immunisation were assessed using the latest disaggregated national health survey immunisation data. The weighted average subregional BCG coverage was 60.7% in 2000, peaked at 83.2% in 2009 and was 65.7% in 2017. The weighted average DTP3 coverage was 42.3% in 2000, peaked at 70.3% in 2009 and was 61.5% in 2017. As of 2017, 46.7% of countries (7/15) had met the GVAP targets on DTP3 coverage. Average weighted subregional immunisation dropouts consistently reduced from 16.4% in 2000 to 7.4% in 2017, meeting the GVAP target in 2008. In most countries, inequalities in BCG, and DTP3 coverage and dropouts were mainly related to equity gaps of more than 20% points between the wealthiest and the poorest, high coverage regions and low coverage regions, and between children of mothers with at least secondary education and those with no formal education. A child's sex and place of residence (urban or rural) minimally determined equity gaps. The West African subregion made progress between 2000 and 2017 in ensuring that its children utilised immunisation services, however, wide equity gaps persist.

Sections du résumé

BACKGROUND BACKGROUND
Several West African countries are unlikely to achieve the recommended Global Vaccine Action Plan (GVAP) immunisation coverage and dropout targets in a landscape beset with entrenched intra-country equity gaps in immunisation. Our aim was to assess and compare the immunisation coverage, dropout and equity gaps across 15 West African countries between 2000 and 2017.
METHODS METHODS
We compared Bacille Calmette Guerin (BCG) and the third dose of diphtheria-tetanus-pertussis (DTP3) containing vaccine coverage between 2000 and 2017 using the WHO and Unicef Estimates of National Immunisation Coverage for 15 West African countries. Estimated subregional median and weighted average coverages, and dropout (DTP1-DTP3) were tracked against the GVAP targets of ≥90% coverage (BCG and DTP3), and ≤10% dropouts. Equity gaps in immunisation were assessed using the latest disaggregated national health survey immunisation data.
RESULTS RESULTS
The weighted average subregional BCG coverage was 60.7% in 2000, peaked at 83.2% in 2009 and was 65.7% in 2017. The weighted average DTP3 coverage was 42.3% in 2000, peaked at 70.3% in 2009 and was 61.5% in 2017. As of 2017, 46.7% of countries (7/15) had met the GVAP targets on DTP3 coverage. Average weighted subregional immunisation dropouts consistently reduced from 16.4% in 2000 to 7.4% in 2017, meeting the GVAP target in 2008. In most countries, inequalities in BCG, and DTP3 coverage and dropouts were mainly related to equity gaps of more than 20% points between the wealthiest and the poorest, high coverage regions and low coverage regions, and between children of mothers with at least secondary education and those with no formal education. A child's sex and place of residence (urban or rural) minimally determined equity gaps.
CONCLUSIONS CONCLUSIONS
The West African subregion made progress between 2000 and 2017 in ensuring that its children utilised immunisation services, however, wide equity gaps persist.

Identifiants

pubmed: 31565416
doi: 10.1136/bmjgh-2019-001713
pii: bmjgh-2019-001713
pmc: PMC6747924
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e001713

Subventions

Organisme : World Health Organization
ID : 001
Pays : International
Organisme : Medical Research Council
ID : MC_UP_A900_1122
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00026/2
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

MMWR Morb Mortal Wkly Rep. 2018 Nov 16;67(45):1261-1264
pubmed: 30439873
Vaccine. 2018 Nov 19;36(48):7361-7368
pubmed: 30366806
Lancet. 2005 Mar 19-25;365(9464):1099-104
pubmed: 15781105
Pan Afr Med J. 2017 Jun 21;27(Suppl 3):1
pubmed: 29296136
PLoS Med. 2013;10(5):e1001391
pubmed: 23667333
N Engl J Med. 2013 Feb 7;368(6):551-60
pubmed: 23388006
Lancet. 2019 May 4;393(10183):1843-1855
pubmed: 30961907
Vaccine. 2014 Apr 17;32(19):2150-9
pubmed: 24598724
Trop Med Health. 2014 Jun;42(2):67-75
pubmed: 25237283
Pan Afr Med J. 2017 Jun 21;27(Suppl 3):5
pubmed: 29296140
Health Aff (Millwood). 2016 Feb;35(2):199-207
pubmed: 26858370
Health Policy Plan. 2014 Mar;29(2):193-203
pubmed: 23426974
Bull World Health Organ. 2017 Feb 1;95(2):128-134
pubmed: 28250513
Wellcome Open Res. 2017 Feb 15;2:12
pubmed: 28459105
Glob Health Action. 2017;10(1):1399749
pubmed: 29185899
Lancet Glob Health. 2016 Sep;4(9):e617-26
pubmed: 27497954
BMC Public Health. 2015 Nov 30;15:1198
pubmed: 26621528

Auteurs

Oghenebrume Wariri (O)

Vaccines and Immunity Theme, MRC Unit the Gambia at the London School of Hygiene and Tropical Medicine, Fajara, Gambia.

Bassey Edem (B)

Vaccines and Immunity Theme, MRC Unit the Gambia at the London School of Hygiene and Tropical Medicine, Fajara, Gambia.

Esin Nkereuwem (E)

Vaccines and Immunity Theme, MRC Unit the Gambia at the London School of Hygiene and Tropical Medicine, Fajara, Gambia.

Oluwatosin O Nkereuwem (OO)

Vaccines and Immunity Theme, MRC Unit the Gambia at the London School of Hygiene and Tropical Medicine, Fajara, Gambia.

Gregory Umeh (G)

World Health Organization Country Office for Nigeria, Abuja, Nigeria.

Ed Clark (E)

Vaccines and Immunity Theme, MRC Unit the Gambia at the London School of Hygiene and Tropical Medicine, Fajara, Gambia.

Olubukola T Idoko (OT)

Vaccines and Immunity Theme, MRC Unit the Gambia at the London School of Hygiene and Tropical Medicine, Fajara, Gambia.
Centre for International Health, Medical Centre, University of Munich, Munchen, Germany.

Terna Nomhwange (T)

World Health Organization Country Office for Nigeria, Abuja, Nigeria.

Beate Kampmann (B)

Vaccines and Immunity Theme, MRC Unit the Gambia at the London School of Hygiene and Tropical Medicine, Fajara, Gambia.
The Vaccine Centre, London School of Hygiene and Tropical Medicine, London, UK.

Classifications MeSH